HIV/AIDS
Pharmaceutical Firm ARTEC, Inc.(TM) Announces Production of TUBERCIN(TM) for Selected Uses in South Africa and the Bahamas - Shareholders Follow-Up Report
Published in TB and Outbreaks Week, December 4th, 2007
Production of TUBERCIN(TM), a revolutionary polysaccharide compound to be used as an HIV/AIDS and ANTI-CANCER immunostimulant, has begun with the focus on South Africa and the Bahamas as mission delivery sites, announces Mr. Gerry Knight, Executive Vice President of ARTEC, Inc.(TM) (Pink Sheets:ATKJ). ARTEC, Inc.(TM) has recently received the final plan for the testing on HIV/AIDS and Tuberculosis Patients in South Africa and anticipates in starting the testing process in early 2008.
Mr. Rodney Watson, ARTEC, Inc.(TM) South African Coordinator, is working on the details and logistics. More detailed information will be made available in future progress reports as soon as...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
More Articles from TB and Outbreaks Week
- Emerging Disease
SARS: a model disease - Obesity
Top researcher argues most physicians aren't prepared to deal with obesity epidemic - Preventable Disease
Number of cases of most vaccine-preventable diseases in US at all-time low - West Nile Virus
Earlier bites by uninfected mosquitoes boost West Nile deaths in lab mice - Autism
Work at Internal Balance, Inc. Created Core Data Used in Recently Published Scientific Paper - Pediatrics
InViragen Receives Funding From the Pediatric Dengue Vaccine Initiative - More from this issue of TB and Outbreaks Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
